FDA reopens comment period for proposed increase in color certification fees

By Cassandra Stern

- Last updated on GMT

"If finalized, the proposed rule will implement a ten cent per pound increase in color certification fees," which is "the first increase proposed since 2005 when the current schedule became effective," said the FDA constituent update. © MilenaKatzer Getty Images
"If finalized, the proposed rule will implement a ten cent per pound increase in color certification fees," which is "the first increase proposed since 2005 when the current schedule became effective," said the FDA constituent update. © MilenaKatzer Getty Images

Related tags Fda compliance Cosmetics

Amidst growing concerns over regulatory costs, the FDA has reopened the comment period for a proposed increase in color certification fees, inviting stakeholders to shape the future of cosmetic and personal care product oversight.

In an update published on April 25, 2024, the U.S. Food and Drug Administration (FDA) declared the reopening of the comment period for the proposed rule titled "Color Additive Certification; Increase in Fees for Certification Services," which was initially announced in the Federal Register on November 2, 2022. This reopening, slated for a 30-day duration, will provide the FDA's administrative record with supporting information and assist in aligning cost and benefit figures with the preliminary regulatory impact analysis.

About the original rule

The original proposed rule, which garnered attention when it was first introduced, seeks to address the escalating costs associated with regulatory oversight and compliance in color additives, which play a key role in cosmetics and personal care product formulations, where they are extensively utilized to enhance the visual appeal of products including makeup, hair dyes, and skincare formulations. According to the FDA's original constituent update published November 1 last year, "if finalized, the proposed rule​ will implement a ten cent per pound increase in color certification fees," which is "the first increase proposed since 2005 when the current schedule became effective." 

As further detailed in the FDA's original constituent update, "an increase in fees is necessary to cover increased operating costs in order to ensure the color certification program continues operating at the high level of quality and efficiency that industry expects," as "manufacturers pay fees, based on the weight of each batch, and these fees support the FDA’s color certification program." 

Significance of the comment period reopening 

Compliance with color additive regulatory standards is crucial for manufacturers and suppliers within the cosmetics and personal care sector. These additives not only contribute to the aesthetic appeal of products but also serve as key components that consumers rely on to identify and distinguish between various product offerings in the marketplace. Therefore, ensuring the safety and regulatory compliance of color additives is essential to maintaining consumer trust and safeguarding public health.

Against this backdrop, the proposed increase in color certification fees carries significant potential implications for cosmetics and personal care product manufacturers and suppliers. While the fee hike is intended to offset the mounting costs of regulatory oversight, it could impact the cost structure and operational dynamics of businesses operating within this sector. Manufacturers may need to recalibrate their product development strategies, manufacturing processes, and pricing models to accommodate the potential increased financial burden associated with color certification.

Therefore, the reopening of the comment period presents a critical opportunity for stakeholders within the cosmetics and personal care industry to contribute their perspectives and insights on the proposed fee increase. By engaging with the FDA's regulatory process, manufacturers and suppliers can help shape policies that balance regulatory objectives, industry needs, and consumer expectations.

As the comment period reopens, industry stakeholders are urged to leverage this opportunity to provide substantive feedback that reflects the unique challenges and considerations facing manufacturers and suppliers to the cosmetics and personal care sectors. Active participation in the regulatory process provides stakeholders with the opportunity to advocate for policies that support innovation, safety, and competitiveness within the marketplace, ultimately benefiting industry stakeholders and consumers.

For further details on how to participate in the comment period and access relevant information, stakeholders are encouraged to visit the FDA's official website and navigate to the designated docket. According to the FDA's update, comments should be submitted to Regulations.gov and identified with the docket number FDA-2022-N-1635​.

Related news

Related products

Ultimate Antimicrobial Solution for BPC

Ultimate Antimicrobial Solution for BPC

Content provided by Acme-Hardesty Company | 11-Oct-2023 | White Paper

Sharomix™ EG10, a versatile broad-spectrum antimicrobial liquid blend for preserving personal care products, ensures safety at usage levels ranging from...

Acme-Hardesty Expands Product Line into Canada

Acme-Hardesty Expands Product Line into Canada

Content provided by Acme-Hardesty Company | 07-Jul-2023 | Product Brochure

Acme-Hardesty’s latest expansion into Canada includes Resplanta®, Botaneco®, and BYK from our partners Sharon Personal Care and Eckart Effect Pigments...

Follow us

Products

View more

Webinars